{"id":"W4200007309","doi":"10.1016/j.annonc.2021.10.182","title":"163P Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study","year":2021,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia","funders":"","keywords":"Medicine; Docetaxel; Gemcitabine; Pembrolizumab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Oncology; Chemotherapy; Cancer; Surgery; Clinical trial; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001759351,0.0008362668,0.001638424,0.0002194958,0.0003558258,0.0009180401,0.0006414491,0.0008764851,0.003672802],"category_scores_gemma":[0.001143549,0.0004445738,0.002527782,0.0005056214,0.0004198209,0.0006829216,0.0004170618,0.002284852,0.0005447429],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006684586,"about_ca_system_score_gemma":0.0007697109,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001752018,"about_ca_topic_score_gemma":0.003203118,"domain_scores_codex":[0.9994221,0.0003239535,0.00003512244,0.00008508476,0.00005702811,0.00007665472],"domain_scores_gemma":[0.9993407,0.0001685287,0.0001855657,0.00005773902,0.00004626925,0.0002011507],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9208896,0.01890647,0.01316308,0.00113718,0.006451883,0.00005027699,0.00009329796,0.0008750635,0.006192857,0.00011195,0.001702143,0.03042614],"study_design_scores_gemma":[0.5761117,0.3403256,0.07269236,0.0001358376,0.005788282,0.0001048198,0.0001025204,0.0006512345,0.002044215,0.0001498501,0.001858863,0.00003467841],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934177,0.002956874,0.0001104183,0.0002278375,0.00008956653,0.0005122112,0.001514364,0.00001683063,0.001154188],"genre_scores_gemma":[0.9944202,0.001735633,0.0002785975,0.0003537761,0.00009738664,0.0006165321,0.001369268,0.000007419557,0.001121126],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003672802,"threshold_uncertainty_score":0.01228678,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1904321503822207,"score_gpt":0.483438736410642,"score_spread":0.2930065860284213,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}